Stereotaxis is trading $1.39, up +6.92%, in pre-market, with the move’s catalyst unclear. - The latest identified company release was September 16 and concerned a conference showcase. - The investor-relations release listing showed no newer announcement through September 24. - U.S. futures were lower, and available evidence does not point to a matching broad-market tailwind.